Xintela AB (XINT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.242x

Based on the latest financial reports, Xintela AB (XINT) has a cash flow conversion efficiency ratio of 0.242x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.74 Million ≈ $-724.90K USD) by net assets (Skr-27.88 Million ≈ $-3.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Xintela AB to measure how many days the company can operate on defensive assets alone.

Xintela AB - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Xintela AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xintela AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xintela AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Surana Solar Limited NSE:SURANASOL	0.116x
Algorae Pharmaceuticals Ltd AU:1AI	-0.327x
Texmo Pipes and Products Limited NSE:TEXMOPIPES	-0.079x
UDAYSHIVAKUMAR INFRA ORD (BSE) NSE:USK	0.029x
Rougier S.A. PA:ALRGR	0.055x
Tecnisa S.A SA:TCSA3	0.020x
Form Bio Co. Ltd. KQ:377220	-0.070x
MDJM Ltd NASDAQ:UOKA	-0.154x

Annual Cash Flow Conversion Efficiency for Xintela AB (2013–2024)

The table below shows the annual cash flow conversion efficiency of Xintela AB from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Xintela AB (XINT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr-5.95 Million ≈ $-640.32K	Skr-40.70 Million ≈ $-4.38 Million	6.841x	+156.41%
2023-12-31	Skr4.38 Million ≈ $471.36K	Skr-53.12 Million ≈ $-5.72 Million	-12.127x	-77.41%
2022-12-31	Skr5.78 Million ≈ $621.70K	Skr-39.49 Million ≈ $-4.25 Million	-6.836x	+37.10%
2021-12-31	Skr3.95 Million ≈ $424.76K	Skr-42.89 Million ≈ $-4.62 Million	-10.867x	-1306.49%
2020-12-31	Skr27.61 Million ≈ $2.97 Million	Skr-21.33 Million ≈ $-2.30 Million	-0.773x	+76.68%
2019-12-31	Skr9.32 Million ≈ $1.00 Million	Skr-30.89 Million ≈ $-3.32 Million	-3.313x	-377.25%
2018-12-31	Skr44.95 Million ≈ $4.84 Million	Skr-31.20 Million ≈ $-3.36 Million	-0.694x	+11.03%
2017-12-31	Skr18.41 Million ≈ $1.98 Million	Skr-14.37 Million ≈ $-1.55 Million	-0.780x	+5.90%
2016-12-31	Skr20.98 Million ≈ $2.26 Million	Skr-17.40 Million ≈ $-1.87 Million	-0.829x	+35.11%
2015-12-31	Skr7.46 Million ≈ $802.92K	Skr-9.54 Million ≈ $-1.03 Million	-1.278x	-193.91%
2014-12-31	Skr9.54 Million ≈ $1.03 Million	Skr-4.15 Million ≈ $-446.50K	-0.435x	+26.64%
2013-12-31	Skr5.08 Million ≈ $546.88K	Skr-3.01 Million ≈ $-324.14K	-0.593x	--

About Xintela AB

ST:XINT Sweden Biotechnology

Market Cap

$14.31 Million

Skr132.93 Million SEK

Market Cap Rank

#26138 Global

#545 in Sweden

Share Price

Skr0.19

Change (1 day)

-4.06%

52-Week Range

Skr0.19 - Skr0.49

All Time High

Skr8.60